GSK2194069
GSK2194069 is an active β-keto reductase (KR) -specific inhibitor of fatty acid synthase (FASN) with an IC50 of 7.7 nM in an assay for the detection of released CoA.GSK2194069 inhibits the proliferation of FAS in cancer cells through the action of acetoacetyl-coenzyme A and NADPH.
Product Specifications
CAS Number
1332331-08-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
428.48
Molecular Formula
C25H24N4O3
Notes
Research use only, not for human use.
Receptor
NADPH | Fatty Acid Synthase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15119220 1 Vial
Lentiviral mouse Vmn2r7 shRNA (UAS) - Lentiviral mouse Vmn2r7 shRNA (UAS, RFP) (100)
Ask
View Details 
248228-ML750 100 µL
LMO3 (LIM Domain only 3 (rhombotin-like 2), DAT1, MGC26081, RBTN3, RBTNL2, RHOM3, Rhom-3) (MaxLight 750) discontinued
Ask
View Details GTR15353237 1 Vial
Lentiviral human ERVMER34-1 shRNA (UAS) - Lentiviral human ERVMER34-1 shRNA (UAS, iRFP) (25)
Ask
View Details 